athenahealth grows its More Disruption Please accelerator program

athenahealth has welcomed three new companies to its More Disruption Please (MDP) program.

The vendor's San Francisco accelerator program announced three portfolio companies that have joined the roster: 

  • Hale Health, a clinical communications platform that connects providers and their patients between visits;
  • Lifesquare, a patient-controlled and patient-owned health data solution that securely relays a patient's essential health information to qualified health care professionals via a quick response (QR) code; and
  • PatientPop, the first practice growth platform and all-in-one health care provider solution for patient acquisition, retention marketing, reputation management, and insights.

All investments receive seeding funding, free office space, mentorship and access to athenahealth's network of 64,000 providers.

"There's substantial opportunity to improve healthcare delivery and create efficiencies within, as well as outside the traditional exam room," said Anna Larson, CEO of Hale Health. "By joining athenahealth's MDP Accelerator program, we can grow the number of healthcare providers who are able to deliver effective and seamless remote care. athenahealth offers an easy path for expedited integration, which will allow our service to become available at scale to thousands of providers. We're thrilled to partner with one of the industry's leading mission-oriented players and plug into the power of healthcare's largest national cloud network."

"Transforming an innovative solution into a business and gaining traction in the healthcare market is an uphill battle that too many entrepreneurs face," said Kyle Armbrester, vice president of business development, athenahealth. "At athenahealth, we are uniquely positioned to support the next generation of healthcare innovators, and see it as our responsibility. We are excited to offer in-house expertise to help our portfolio companies refine their solutions and scale within the athenahealth userbase and beyond."

Meanwhile, the MDP Accelerator program is looking for high-potential startups with provider-facing solutions. The MDP Austin Accelerator is now accepting applications from local, mid-stage healthcare startups, while space for the accelerator will be determined in the coming months. MDP Accelerator locations in Boston and San Francisco will continue to assess applications on a rolling basis.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.